NCT01410318Active, not recruiting
Progression of Early Subclinical Atherosclerosis
Early Detection and Progression of Subclinical Atherosclerosis and Its Relationship to Coronary Risk Factors
Source: ClinicalTrials.gov · Last updated 29 Apr 2021
Brief summary (registry, in English)
The overall objective of this study is to characterize the prevalence and progression rate of subclinical atherosclerotic lesions and to study their association to the imaging characteristics of atheroma plaques and to the presence of genetic, epigenetic, metabolomic, and environmental factors, including dietary habits, physical activity, biorhythms, psychosocial characteristics, and exposure to environmental pollutants
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 4184 (actual)
- First submitted
- 2 Aug 2011
- Start date
- 14 Jun 2010
- Primary completion date
- 30 Jun 2030
- Lead sponsor
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Diseases
- Heart failure, Coronary artery disease, Stroke
- NCT number
- NCT01410318
What you commit to
- Study type: Observational
- Participants enrolled: 4184
- From 14 Jun 2010 to the primary completion date, 30 Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior angioplasty or heart surgery
- A chest CT in the previous year
Other illness
- Myocardial Infarction
- Angina pectoris
- Stroke, either transient or with sequelae
- Peripheral vascular disease
- Other heart diseases
- Subjects with the following conditions will also be excluded:
- Active treatment for any cancer
Lab values
- Renal failure with creatinine clearance \<60 mL/min, as estimated by the Cockcroft and Gault formula
Age
- Any disease that decreases life expectation to ≤6 years
Other
- Atrial fibrillation
- Pregnancy
- Morbid obesity (BMI ≥40)
- Pacemaker, implantable automatic defibrillator, or any implanted device that contraindicates MRI
Who the study is looking for
- Employees of the Banco de Santander Group
- Age between 40-54 years.
Age in the registry: 40 years to 54 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ciudad Financiera del Grupo Santander Coordinator of this site? Confirm its status | Boadilla del Monte | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.